The number of people recovering from COVID-19 in Pakistan exceeds 1 million and the death toll is close to 25,000

[ad_1]

  • After recording 3,027 survivors, NCOC counted 1,002,430 recovered cases.
  • The positive rate in Pakistan is 6.23%.
  • The number of active or currently sick patients is 89,673

Islamabad: According to national command and operation data, the number of patients recovering from COVID-19 in Pakistan exceeded 1 million on Friday, and the death toll was close to 25,000.

NCOC statistics show that after 51,982 COVID-19 tests have been conducted, 3,239 new cases have been reported in the past 24 hours, and the total number of infections has risen to 1,116,886.

The number of patients who are active or currently sick is 89,673, which is the highest level since 89,661 active cases were recorded in the country on May 2.

After recording 3,027 survivors, NCOC counted 1,002,430 recovered cases. At the same time, another 70 people died of this disease, bringing the death toll to 24,783.

As of August 20, out of 51,982 tests, the daily positive rate or the rate of infected patients was 6.23%. The World Health Organization recommends a ratio of less than 5%, because a high number may mean high transmission.

Read more: Coronavirus cases in Pakistan are on the rise again

The average number of new infections reported daily in Pakistan has increased by more than 940 in the past three weeks, which is 16% of the previous peak. Reuters.

COVID-19 infections in Pakistan are decreasing, with an average of 4,050 new infections being reported every day. This is 69% of the peak-the highest daily average reported on June 17.

To date, Pakistan has received at least 44,736,977 doses of COVID-19 vaccine. Assuming that everyone needs two doses of vaccine, this is enough to vaccinate approximately 10.3% of the country’s population.

In last week’s report, Pakistan took an average of about 716,137 doses per day. At this rate, it will take 61 days to provide sufficient doses for the other 10% of the population.

[ad_2]

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker